
We are proud to have participated in @vestibularveda’s #BalanceAwarenessWeek to raise awareness for people who have #VestibularDisorders and balance issues

Sensorion is a clinical stage biopharmaceutical company developing small molecule therapeutics that address unmet need in inner ear diseases.

We are proud to have participated in @vestibularveda’s #BalanceAwarenessWeek to raise awareness for people who have #VestibularDisorders and balance issues

Though not commonly talked about, disorders of the vestibules that affect balance are much more prevalent than most are aware. Here you can find quick facts and graphics about these disorders to learn more. https://t.co/9QmtXOIwqj

Looking to find a way to make a difference for people who suffer with a #VestibularDisorder? Check out @vestibularveda’s page about how one can help and take action. #BalanceAwarenessWeek https://t.co/cSxSyLYPi0

The different types of vestibular disorders can lead to a number of balance and falling issues in patients who suffer them. $ALSEN is developing SENS-111 to potentially help a group of patients, suffering from AUV, alleviate their balance problems. https://t.co/wpIvxFMODv

Want learn more about #VestibularDisorders? @vestibularveda provides an overview explaining what happens to the human sense of balance when the sensory information is disrupted in your ear https://t.co/ysj2janZbt #BalanceAwarenessWeek

The human balance system is complex and is often taken for granted. For this reason, awareness is key to maintaining a healthy balance system. Learn more here https://t.co/K2tiDCEcZz

Today is the first day of #BalanceAwarenessWeek! Learn more about @vestibularveda and their call to action to raise awareness about balance and falling issues for people who suffer from a #VestibularDisorder vestibular.org/

We are pleased to sponsor the @childrenscause externally-led patient focused drug development workshop on the topic of #chemo-induced #hearingloss in pediatric patients. $ALSEN is developing SENS-401 for the treatment of cisplatin-induced toxicity #PFDD https://t.co/lUhnsHO2v5

.@SensorionPharma to Begin Patient Enrollment for Safety Study of Vertigo Drug, Seliforant. #vertigo #dizziness #audpeeps #pharma ow.ly/ewTk30ltUzP

We are excited to be participating in @vestibularveda’s #BalanceAwarenessWeek to bring awareness to balance and fall issues! Vestibular disorders represent an area of significant unmet need. Click here to learn more about this important initiative! https://t.co/0MAYxIdxvc

We are happy to announce that we will be presenting data in three posters at the 55th Inner Ear Biology Workshop on September 6th. See the press release below for more details #IEB2018 https://t.co/e0lh3hnbab

People react differently to the news that they or a loved one has #hearingloss. Like many other difficult diagnoses, doctors must employ a different approach for delivering this news from patient to patient https://t.co/ls3WVCd2ev

A Non-Sedating Option for Vertigo and Nausea? #audpeeps #dizzy @SensorionPharma ow.ly/TVOa30lwFyi

In our latest Working Life feature, Sensorion CEO Nawal Ouzren discusses the path she has taken throughout her career and gives her advice on replicating the successes she has realised along the way https://t.co/qNzkLFPNmo

.@SensorionPharma to Begin Patient Enrollment for Safety Study of Vertigo Drug, Seliforant. #vertigo #dizziness #audpeeps #pharma ow.ly/ewTk30ltUzP

Today $ALSEN received European authorization to initiate its Phase 2 trial for SENS-401 to help treat adults who suffer from sudden sensorineural #hearingloss. Read the full press release https://t.co/HJ8OuHXKSv